HDAC8-IN-3

Modify Date: 2024-04-03 11:34:03

HDAC8-IN-3 Structure
HDAC8-IN-3 structure
Common Name HDAC8-IN-3
CAS Number 2432825-93-7 Molecular Weight 396.44
Density N/A Boiling Point N/A
Molecular Formula C18H12N4O3S2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of HDAC8-IN-3


HDAC8-IN-3 (compound P19) is a potent HDAC8 inhibitor with IC50 value of 9.3 μM and produces thermal stabilization. HDAC8-IN-3 has cytotoxicity and induces apoptosis in leukemic cell lines[1].

 Names

Name HDAC8-IN-3

 HDAC8-IN-3 Biological Activity

Description HDAC8-IN-3 (compound P19) is a potent HDAC8 inhibitor with IC50 value of 9.3 μM and produces thermal stabilization. HDAC8-IN-3 has cytotoxicity and induces apoptosis in leukemic cell lines[1].
Related Catalog
Target

HDAC8:9.3 μM (IC50)

HDAC4:>50 μM (IC50)

HDAC1:>50 μM (IC50)

HDAC2:41 μM (IC50)

HDAC3:>50 μM (IC50)

HDAC5:>50 μM (IC50)

HDAC6:17 μM (IC50)

HDAC8:>50 μM (IC50)

In Vitro HDAC8-IN-3 (compound P19) (5-200 μM, 48 hours; HEK293T cells) has cytotoxicity in leukemic cell lines[1]. HDAC8-IN-3 (compound P19) (50 μM) inhibits glucose transporter 1 (GLUT1)-mediated glucose transport by down-regulating GLUT1 expression (IC50 = 28.2 μM)[1]. HDAC8-IN-3 (compound P19) (79.9 μM; 24 hours) can induce apoptotic death in the CEM cell line[1]. Cell Cytotoxicity Assay[1] Cell Line: K562, KCL22 and CEM leukemia cells. Concentration: 50 μM Incubation Time: 48 hours Result: Inhibited with IC50 values of 79.9, 85.4 and 43.2 μM for CEM, K562 and KCL22 cells, respectively. Apoptosis Analysis[1] Cell Line: CEM cells Concentration: 79.9 μM Incubation Time: 24 hours Result: The percentage of apoptotic cells was recorded as 60.97%.
References

[1]. Upadhyay N, et al. Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation. Bioorg Chem. 2020 Jul;100:103934.

 Chemical & Physical Properties

Molecular Formula C18H12N4O3S2
Molecular Weight 396.44